Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 17 | 0 | 0 | 2 | 0 |
| Cost of Goods | 1 | N/A | N/A | 1 | 0 |
| Gross Profit | 17 | N/A | N/A | 1 | 0 |
| Operating Expenses | 918 | 484 | 559 | 999 | 160 |
| Operating Income | -901 | -487 | -559 | -997 | -159 |
| Interest Expense | 0 | 0 | 0 | 186 | 83 |
| Other Income | 37 | -9 | 3 | -192 | 3 |
| Pre-tax Income | -864 | -496 | -557 | -1,375 | -239 |
| Net Income Continuous | -864 | -496 | -557 | -1,375 | -239 |
| Net Income Discontinuous | -67 | -294 | -77 | N/A | N/A |
| Net Income | $-931 | $-790 | $-634 | $-1,375 | $-239 |
| EPS Basic Total Ops | -0.03 | 0.00 | -0.01 | -0.04 | -0.01 |
| EPS Basic Continuous Ops | -0.03 | 0.01 | -0.01 | -0.04 | -0.01 |
| EPS Basic Discontinuous Ops | 0.00 | -0.01 | 0.00 | N/A | N/A |
| EPS Diluted Total Ops | -0.03 | 0.00 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Continuous Ops | -0.03 | 0.01 | -0.01 | -0.04 | -0.01 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.01 | 0.00 | N/A | N/A |
| EBITDA(a) | $-800 | $-366 | $-316 | $-594 | $-77 |